TEVA vs. IVV
Compare and contrast key facts about Teva Pharmaceutical Industries Limited (TEVA) and iShares Core S&P 500 ETF (IVV).
IVV is a passively managed fund by iShares that tracks the performance of the S&P 500 Index. It was launched on May 15, 2000.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: TEVA or IVV.
Correlation
The correlation between TEVA and IVV is 0.38, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
TEVA vs. IVV - Performance Comparison
Key characteristics
TEVA:
0.84
IVV:
1.94
TEVA:
1.72
IVV:
2.60
TEVA:
1.22
IVV:
1.35
TEVA:
0.45
IVV:
2.93
TEVA:
5.97
IVV:
12.19
TEVA:
6.18%
IVV:
2.02%
TEVA:
44.15%
IVV:
12.72%
TEVA:
-90.80%
IVV:
-55.25%
TEVA:
-74.53%
IVV:
-1.31%
Returns By Period
In the year-to-date period, TEVA achieves a -22.60% return, which is significantly lower than IVV's 2.72% return. Over the past 10 years, TEVA has underperformed IVV with an annualized return of -10.74%, while IVV has yielded a comparatively higher 13.40% annualized return.
TEVA
-22.60%
-19.68%
0.89%
37.80%
7.11%
-10.74%
IVV
2.72%
1.70%
16.01%
23.82%
14.33%
13.40%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
TEVA vs. IVV — Risk-Adjusted Performance Rank
TEVA
IVV
TEVA vs. IVV - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Teva Pharmaceutical Industries Limited (TEVA) and iShares Core S&P 500 ETF (IVV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
TEVA vs. IVV - Dividend Comparison
TEVA has not paid dividends to shareholders, while IVV's dividend yield for the trailing twelve months is around 1.26%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
TEVA Teva Pharmaceutical Industries Limited | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 4.49% | 3.75% | 2.07% | 2.38% |
IVV iShares Core S&P 500 ETF | 1.26% | 1.30% | 1.44% | 1.66% | 1.20% | 1.57% | 1.99% | 2.21% | 1.75% | 2.01% | 2.27% | 1.83% |
Drawdowns
TEVA vs. IVV - Drawdown Comparison
The maximum TEVA drawdown since its inception was -90.80%, which is greater than IVV's maximum drawdown of -55.25%. Use the drawdown chart below to compare losses from any high point for TEVA and IVV. For additional features, visit the drawdowns tool.
Volatility
TEVA vs. IVV - Volatility Comparison
Teva Pharmaceutical Industries Limited (TEVA) has a higher volatility of 17.02% compared to iShares Core S&P 500 ETF (IVV) at 3.98%. This indicates that TEVA's price experiences larger fluctuations and is considered to be riskier than IVV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.